SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,797,000 | +24.8% | 259,023 | +18.4% | 0.00% | 0.0% |
| Q3 2016 | $2,241,000 | -21.7% | 218,679 | -0.2% | 0.00% | -25.0% |
| Q2 2016 | $2,861,000 | +47.2% | 219,053 | +24.0% | 0.00% | +33.3% |
| Q1 2016 | $1,943,000 | +21.5% | 176,671 | +1.7% | 0.00% | +50.0% |
| Q4 2015 | $1,599,000 | +32.6% | 173,775 | -0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,206,000 | -31.2% | 173,793 | -2.6% | 0.00% | 0.0% |
| Q2 2015 | $1,752,000 | +24.6% | 178,435 | +12.5% | 0.00% | 0.0% |
| Q1 2015 | $1,406,000 | +2.3% | 158,658 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $1,375,000 | +26.5% | 156,976 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,087,000 | +30.8% | 157,801 | -0.1% | 0.00% | +100.0% |
| Q2 2014 | $831,000 | +13.5% | 157,993 | -1.8% | 0.00% | 0.0% |
| Q1 2014 | $732,000 | -8.5% | 160,897 | +1.4% | 0.00% | 0.0% |
| Q4 2013 | $800,000 | -2.7% | 158,723 | -2.1% | 0.00% | 0.0% |
| Q3 2013 | $822,000 | +5.1% | 162,104 | +2.8% | 0.00% | 0.0% |
| Q2 2013 | $782,000 | – | 157,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |